C-tri, to file international patent for valienamine production process.

Published: 2005-12-26 07:00:00

Updated: 2005-12-26 07:00:00

C-Tris Inc., a life science venture company announced on Dec. 21 that the international patent for the production process of the intermediate compound, valienamine, of Voglibose, an anti-diabetic drug, was filed.

Valienamine has been hardly supplied because of no economic synthetic method and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK